Women may face heart attack risk with lower plaque level than men, Shows study Dr. Kamal Kant Kohli24 Feb 2026 9:00 PM ISTLess artery-clogging plaque in women's arteries did not appear to protect them from heart disease compared to men, according to a study published...
Dry powder inhalers can improve patient outcomes and lower environmental impact: shows JAMA Study Dr. Kamal Kant Kohli24 Feb 2026 8:30 PM ISTNew research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to...
Osteoporosis drug shows potential against diseases caused by excess iron, finds study Dr. Kamal Kant Kohli24 Feb 2026 8:30 PM ISTResearchers at the University of São Paulo (USP) in Brazil have discovered that two osteoporosis drugs (etidronate and tiludronate) may combat...
Effectiveness of exercise to ease osteoarthritis symptoms likely minimal and transient, suggests study Dr. Kamal Kant Kohli24 Feb 2026 8:30 PM ISTThe effectiveness of exercise therapy to ease the symptoms of osteoarthritis is likely minimal, short lived, and probably no better than no treatment...
Women Prefer In-Clinic Cervical Cancer Screening to in-home screening; Evidence Supports Longer Screening Intervals Dr Riya Dave24 Feb 2026 8:30 PM ISTTwo recent analyses highlight evolving perspectives on cervical cancer (CC) screening. One study from the United States found that a majority of women...
Cardiometabolic Risk Factors: Indian Study Highlights Rising Prevalence Aashi verma24 Feb 2026 8:30 PM ISTA recent study in India reveals a high cardiometabolic burden, especially in urban areas, with prevalence rates of 44% for hypertension, 21% for...
Nexplanon Now Approved for 5-Year Pregnancy Prevention by FDA Dr. Kamal Kant Kohli24 Feb 2026 8:30 PM ISTThe FDA has extended approval of Nexplanon (etonogestrel implant) for pregnancy prevention in women of reproductive age from 3 years to 5...
FDA Approves Milsaperidone as First-Line Treatment for Schizophrenia and Bipolar I Disorder Dr. Kamal Kant Kohli24 Feb 2026 8:15 PM ISTThe U.S. Food and Drug Administration has approved milsaperidone (Bysanti) tablets as a first-line therapy for adults with schizophrenia and manic or...
Underbite associated with tooth loss risk, finds study Dr. Kamal Kant Kohli24 Feb 2026 8:15 PM ISTCrooked teeth or a misaligned bite can cause a whole host of problems, including speech issues and/or difficulty eating or properly cleaning teeth....
Hemorrhagic Gastric Diverticulum Mimics Adrenal Tumor: A Case Report Dr Riya Dave24 Feb 2026 8:00 PM ISTA case report published in BMC Surgery by Jia Li. and colleagues has shown that a hemorrhagic gastric diverticulum can very much resemble a left...
Dapagliflozin May Reduce Liver Fat in Type 2 Diabetes Independent of Weight Loss: Study Dr Riya Dave24 Feb 2026 9:30 AM ISTResearchers have found in a secondary analysis of a clinical trial published in Obesity that taking dapagliflozin 10 mg daily for 12 months was...
CagriSema Fails to Demonstrate Noninferiority to Tirzepatide for Weight Loss: Phase 3 REDEFINE Trial Dr. Kamal Kant Kohli24 Feb 2026 9:15 AM ISTTopline results from a phase 3 clinical trial compared CagriSema with tirzepatide in patients with obesity. CagriSema is a fixed-dose combination of...
